How have STDAF shares performed in 2024?

STADA Arzneimittel Aktiengesellschaft's stock was trading at $110.42 at the beginning of 2024. Since then, STDAF stock has increased by 0.0% and is now trading at $110.42. View the best growth stocks for 2024 here .

How do I buy shares of STADA Arzneimittel Aktiengesellschaft?

Shares of STDAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:STDAF

STADA Arzneimittel Aktiengesellschaft (STDAF) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free STDAF Stock Alerts

$110.42

0.00 (0.00%)

(As of 10/24/2022)

Compare

Today's Range: $110.42
▼
$110.42
50-Day Range: $110.42
▼
$110.42
52-Week Range: $75.15
▼
$115.00

Volume: N/A
Average Volume: 180 shs
Market Capitalization: $6.88 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get STADA Arzneimittel Aktiengesellschaft alerts:

Ad Paradigm Press

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

About STADA Arzneimittel Aktiengesellschaft Stock (OTCMKTS:STDAF)

STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.

STDAF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

STDAF Stock News Headlines

February 22, 2024 | washingtonpost.com

STAFF NEWS

January 10, 2024 | seekingalpha.com

KPLUY K+S Aktiengesellschaft

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

January 10, 2024 | seekingalpha.com

KPLUY K+S Aktiengesellschaft

July 21, 2023 | investing.com

STADA Arzneimittel AG V (SAZA)

May 30, 2023 | bbc.co.uk

CBI hired 'toxic' staff and failed to sack offenders

January 28, 2023 | seekingalpha.com

Sartorius Aktiengesellschaft 2022 Q4 - Results - Earnings Call Presentation

See More Headlines

Receive STDAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STADA Arzneimittel Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/17/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medicinals & Botanicals
Sub-Industry: N/A
Current Symbol: OTCMKTS:STDAF
Previous Symbol: NASDAQ:STDAF
CUSIP: N/A
CIK: N/A
Web: www.stada.com
Phone: (496) 101-6030
Fax: 49-61-0160-3259
Employees: 12,500
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 2.23
Current Ratio: 1.54
Quick Ratio: 0.99

Sales & Book Value

Annual Sales: $3.84 billion
Price / Sales: 1.79
Cash Flow: $11.12 per share
Price / Cash Flow: 9.93
Book Value: $23.11 per share
Price / Book: 4.78

Miscellaneous

Outstanding Shares: 62,342,000
Free Float: N/A
Market Cap: $6.88 billion
Optionable: Not Optionable
Beta: 0.38

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Peter Goldschmidt
Chairman-Executive Board
Wolfgang Ollig
Chief Financial Officer
Miguel Pagan Fernandez
Chief Technical Officer
Yann Brun
EVP, Head-Regulatory & Business Development
Frank Seiler
Head-Investor Relations Contact

Key Competitors

View All Competitors

STDAF Stock Analysis - Frequently Asked Questions

How have STDAF shares performed in 2024?: STADA Arzneimittel Aktiengesellschaft's stock was trading at $110.42 at the beginning of 2024. Since then, STDAF stock has increased by 0.0% and is now trading at $110.42.
View the best growth stocks for 2024 here.
How do I buy shares of STADA Arzneimittel Aktiengesellschaft?: Shares of STDAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:STDAF) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial